Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis

被引:16
作者
Katzman, Joanna G. [1 ,2 ,3 ]
Greenberg, Nina H. [4 ]
Takeda, Mikiko Y. [5 ]
Balasch, Monica Moya [1 ]
机构
[1] Univ New Mexico, Dept Neurosurg, Sch Med, MSC 10-5615, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA
[3] Univ New Mexico, Coll Nursing, MSC 10-5615, Albuquerque, NM 87131 USA
[4] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA
[5] Univ New Mexico, Dept Pharm Practice & Adm Serv, Coll Pharm, Albuquerque, NM 87131 USA
关键词
characteristics; harm reduction; naloxone; opioid; overdose; INJECTION-DRUG USERS; HEROIN OVERDOSE; NALOXONE;
D O I
10.1097/ADM.0000000000000461
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: The primary outcome of this study is to identify characteristics of study participants in a large opioid treatment program (OTP) for opioid use disorder (OUD) who used take-home naloxone to perform 1 or more opioid overdose (OD) reversal(s) in the community. Methods: This 6-month prospective cohort study provided take-home naloxone and opioid OD education for 287 study participants with OUD. Characteristics associated with use of the take-home naloxone were determined from among 16 variables using multivariable logistic regression. Results: The study participants who had greater odds of using the take-home naloxone to perform OD reversals, compared to those who did not use the take-home naloxone, (a) received emergency room care themselves for OD (OR = 4.89, 95% CI 1.54-15.52, P = 0.007), (b) previously witnessed someone else OD (OR = 5.67, 95% CI 1.24-25.87, P = 0.025), (c) tested positive for 2 or more illicit substances at their 6-month urine analysis (OR = 5.26, 95% CI 1.58-17.54, P = 0.007) or were missing their 6-month urine analysis (OR = 3.46, 95% CI 1.42-8.43, P = 0.006). In addition, they had greater odds of being (d) less than 30 years old (OR = 2.80, 95% CI 1.02-7.66, P = 0.045), and (e) Hispanic (OR = 3.98, 95% CI 1.41-11.21, P = 0.009). Conclusions: This study prospectively identified several characteristics of patients enrolled in an OTP with increased odds of using take-home naloxone in their social networks. Future harm reduction efforts may benefit by using targeted characteristics to identify those most likely to use naloxone in their communities.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [1] Opioid Use Disorder Education for Students and the Future of Opioid Overdose Treatment
    Balapal, Neha
    Ankem, Amala
    Shyamsundar, Saishravan
    He, Shuhan
    JMIR MEDICAL EDUCATION, 2022, 8 (03):
  • [2] Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program
    Katzman, Joanna G.
    Takeda, Mikiko Y.
    Greenberg, Nina
    Moya Balasch, Monica
    Alchbli, Amal
    Katzman, William G.
    Salvador, Julie G.
    Bhatt, Snehal R.
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [3] Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients
    Crystal, Stephen
    Nowels, Molly
    Samples, Hillary
    Olfson, Mark
    Williams, Arthur Robin
    Treitler, Peter
    DRUG AND ALCOHOL DEPENDENCE, 2022, 232
  • [4] Intervention in an opioid overdose event increases interest in treatment among individuals with opioid use disorder
    Jones, Jermaine D.
    Campbell, Aimee N.
    Brandt, Laura
    Castillo, Felipe
    Abbott, Rebecca
    Comer, Sandra D.
    SUBSTANCE ABUSE, 2021, 42 (04) : 407 - 411
  • [5] A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorder
    Jones, Jermaine D.
    Campbell, Aimee N.
    Brandt, Laura
    Metz, Verena E.
    Martinez, Suky
    Wall, Melanie
    Corbeil, Thomas
    Andrews, Howard
    Castillo, Felipe
    Neale, Joanne
    Strang, John
    Ross, Stephen
    Comer, Sandra D.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 237
  • [6] Overdose history is associated with postdetoxification treatment preference for persons with opioid use disorder
    Stein, Michael D.
    Flori, Jessica N.
    Risi, Megan M.
    Conti, Micah T.
    Anderson, Bradley J.
    Bailey, Genie L.
    SUBSTANCE ABUSE, 2017, 38 (04) : 389 - 393
  • [7] Rates of Receiving Medication for Opioid Use Disorder and Opioid Overdose Deaths During the Early Synthetic Opioid Crisis: A County-level Analysis
    Santaella-Tenorio, Julian
    Rivera-Aguirre, Ariadne
    Hepler, Staci A.
    Kline, David M.
    Cantor, Jonathan
    Deyoreo, Maria
    Martins, Silvia S.
    Krawczyk, Noa
    Cerda, Magdalena
    EPIDEMIOLOGY, 2025, 36 (02) : 186 - 195
  • [8] Impact of a community-based naloxone distribution program on opioid overdose death rates
    Naumann, Rebecca B.
    Durrance, Christine Piette
    Ranapurwala, Shabbar I.
    Austin, Anna E.
    Proescholdbell, Scott
    Childs, Robert
    Marshall, Stephen W.
    Kansagra, Susan
    Shanahan, Meghan E.
    DRUG AND ALCOHOL DEPENDENCE, 2019, 204
  • [9] Evaluation of a Medicaid Lock-in Program Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk
    Naumann, Rebecca B.
    Roberts, Andrew W.
    Marshall, Stephen W.
    Skinner, Asheley C.
    MEDICAL CARE, 2019, 57 (03) : 213 - 217
  • [10] Behavioral pharmacology of methocinnamox: A potential new treatment for opioid overdose and opioid use disorder
    Maguire, David R.
    France, Charles P.
    JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR, 2023, 119 (02) : 392 - 406